How should a patient with gallbladder adenomyomatosis (adenomyocytosis) and unexplained transaminitis be managed surgically?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Gallbladder Adenomyomatosis with Transaminitis: Surgical Approach

Laparoscopic cholecystectomy is the definitive surgical treatment for gallbladder adenomyomatosis presenting with transaminitis, as the transaminitis likely indicates biliary obstruction or inflammation requiring removal of the gallbladder. 1, 2

Initial Diagnostic Workup

Before proceeding to surgery, you must rule out common bile duct stones (CBDS) as the cause of transaminitis:

  • Assess risk stratification for CBDS using clinical and laboratory criteria: total bilirubin >1.8 mg/dL, common bile duct diameter >6 mm on ultrasound, abnormal liver biochemical tests, age >55 years, or clinical evidence of cholangitis 1

  • For high-risk patients (bilirubin >1.8 mg/dL or CBD >6 mm): Obtain preoperative ERCP, or plan intraoperative cholangiography (IOC) or laparoscopic ultrasound (LUS) depending on local expertise 1

  • For intermediate-risk patients: Consider MRCP or EUS preoperatively to exclude CBDS with 93-95% sensitivity and 96-97% specificity, avoiding unnecessary ERCP and its 1-10% complication rate 1

Surgical Management Algorithm

Primary Recommendation

Proceed with laparoscopic cholecystectomy as first-line treatment unless the patient is in septic shock or has absolute anesthesiologic contraindications 1, 2

The rationale is straightforward:

  • Adenomyomatosis itself is benign but can cause symptoms including right upper quadrant pain and potentially biliary obstruction 3, 4, 5
  • Transaminitis in this context suggests either biliary obstruction from associated stones (present in 50-90% of adenomyomatosis cases) or inflammation requiring definitive treatment 4
  • Laparoscopic cholecystectomy offers low complication rates (2-8% morbidity, 0.2-0.7% mortality) with shorter hospital stays and faster recovery 2, 6

Intraoperative Considerations

Achieve Critical View of Safety (CVS) before dividing any structures:

  • Clear the hepatocystic triangle of all fat and fibrous tissue 2
  • Separate the lower third of the gallbladder from the liver bed 2
  • Visualize only two structures (cystic duct and cystic artery) entering the gallbladder 2

If CVS cannot be achieved due to inflammation or unclear anatomy:

  • Consider subtotal cholecystectomy rather than risking bile duct injury 2
  • Perform intraoperative cholangiography or laparoscopic ultrasound if anatomy remains unclear 2
  • Convert to open surgery rather than persisting with difficult dissection 2

Management of Concurrent CBDS

If CBDS is identified preoperatively or intraoperatively, remove stones using one of these equivalent approaches:

  • Preoperative ERCP with sphincterotomy 1
  • Intraoperative ERCP (rendezvous technique) 1
  • Laparoscopic or open common bile duct exploration 1
  • Postoperative ERCP with sphincterotomy 1

All techniques show equivalent morbidity, mortality, and success rates; choose based on local expertise and availability 1

Special Considerations for Adenomyomatosis

Diagnostic Certainty

While MRI can definitively diagnose adenomyomatosis with the characteristic "pearl-necklace sign" and distinguish it from gallbladder carcinoma 6, 7, if there is any diagnostic doubt about malignancy, proceed with cholecystectomy 4

The segmental type of adenomyomatosis carries increased malignancy risk and warrants cholecystectomy even if asymptomatic 3, 4

Symptomatic Disease

Your patient has transaminitis, which constitutes a symptom requiring intervention:

  • Symptomatic adenomyomatosis of any type is an indication for cholecystectomy 3, 4
  • Cholecystectomy results in complete disappearance of symptoms in symptomatic cases 4
  • Conservative management risks recurrent biliary complications: 30% of patients managed non-operatively develop recurrent gallstone-related complications over 14 years 1, 8

Common Pitfalls to Avoid

Do not delay surgery for extensive imaging workup if the diagnosis is clear and the patient is symptomatic—this only increases the risk of complications during the waiting period 2

Do not perform ERCP without planning cholecystectomy—ERCP alone without cholecystectomy results in significantly higher rates of recurrent biliary complications 8

Do not persist with difficult laparoscopic dissection if CVS cannot be achieved—bile duct injury is the most feared complication, and conversion to open or subtotal cholecystectomy is safer 2

Do not assume transaminitis will resolve without addressing the gallbladder—the adenomyomatosis with associated inflammation or stones is the likely source requiring definitive surgical treatment 1, 4

Timing of Surgery

Perform laparoscopic cholecystectomy as soon as feasible once CBDS has been excluded or managed 2, 8

  • Early surgery (within 72 hours if acute inflammation is present) reduces conversion rates and hospital stay 2
  • Delayed surgery beyond 10 days is associated with 30% incidence of recurrent complications 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laparoscopic Cholecystectomy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Gallbladder adenomyomatosis: Diagnosis and management.

Journal of visceral surgery, 2017

Guideline

Diagnostic Imaging and Management of Gallbladder Adenomyomatosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Symptomatic Gallstones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.